Overall, these results highlight the potential of certain Ramalin derivatives in modulating neuroinflammatory responses through NLRP3 inhibition, which could be advantageous for developing therapeutics targeting neurodegenerative diseases like AD. Here, NLRP3 is linked to Alzheimer disease.